888-430-5470
  • Facebook
  • Twitter
  • Google
  • Facebook
  • Twitter
  • Google
Drug Outlook
  • Drugs & Devices
    • Actos
    • Benicar
    • Da Vinci Robots
    • Essure
    • Granuflo
    • Hip Implants
    • INFUSE® Bone Graft
    • IVC Filters
    • Physiomesh
    • Power Morcellator
    • Pradaxa
    • Risperdal
    • SGLT2 Inhibitors
    • Talcum Powder
    • Testosterone Therapy
    • Transvaginal Mesh
    • Viagra
    • Xarelto
    • Zofran
  • Manufacturers
    • AbbVie & Abbott
    • Boehringer Ingelheim
    • Eli Lilly
    • GlaxoSmithKline
    • Takeda Pharma
  • Current Lawsuits
    • Case Evaluation
  • News
  • DrugHub©
Select Page
  • Drugs & Devices
    • Actos
    • Benicar
    • Da Vinci Robots
    • Essure
    • Granuflo
    • Hip Implants
    • INFUSE® Bone Graft
    • IVC Filters
    • Physiomesh
    • Power Morcellator
    • Pradaxa
    • Risperdal
    • SGLT2 Inhibitors
    • Talcum Powder
    • Testosterone Therapy
    • Transvaginal Mesh
    • Viagra
    • Xarelto
    • Zofran
  • Manufacturers
    • AbbVie & Abbott
    • Boehringer Ingelheim
    • Eli Lilly
    • GlaxoSmithKline
    • Takeda Pharma
  • Current Lawsuits
    • Case Evaluation
  • News
  • DrugHub©

Gilead Sciences Delayed Release of Better HIV Treatment

by Mooslet Writing Services | Jun 7, 2016 | Prescription Drugs

Gilead Sciences is being sued by an AIDS advocacy group which claims the pharmaceutical giant halted development on an improved HIV drug because it feared cannibalizing the profits of an existing drug. AIDS Healthcare Foundation, a Los Angeles nonprofit, accuses the...

Eli Lilly Plans to Launch 20 New Drugs

by Mooslet Writing Services | Jun 6, 2016 | Big Pharma Business

In a presentation to investors last month, Eli Lilly revealed its ambitious plan to launch 20 new drugs over the next seven years. The Indianapolis-based pharmaceutical behemoth also declared its intention to add more uses to its existing therapies – all by the...

J&J Reputation Tanks As More Lawsuits Are Filed

by Mooslet Writing Services | Jun 2, 2016 | Big Pharma Lawsuits

Johnson & Johnson (J&J) has an image problem. Consumer goodwill ratings for the company have plummeted to new lows lately. According to the website BrandIndex, which tracks brand perception among the public, J&J’s ongoing legal troubles are the source of...

Pharma Companies, False Charity, and High Drug Costs

by Mooslet Writing Services | Jun 1, 2016 | Big Pharma Business

Amid bad press for rising prescription drug costs, drug companies have discovered a new revenue stream that comes from an unlikely place: charity donations. Yes, drug companies can make more money by donating to charity – here’s how it works. Step 1: Pharma...

Genentech Accused of Shorting Cancer Drugs

by Mooslet Writing Services | May 30, 2016 | Big Pharma Lawsuits

Nine cancer hospitals in seven different states have launched lawsuits against a drug maker they say is short-changing them on cancer drug Herceptin. San Francisco-based manufacturer Genentech is accused of shipping less medication than claimed on its packaging...

FDA Delays Decision About Improving Medication Labels

by Mooslet Writing Services | May 26, 2016 | FDA

Last week, the US Food and Drug Administration (FDA) again delayed making a decision about whether generic drug makers should be required to keep their medication labels updated about newly discovered risks. The delay marked the third time that the FDA has postponed...

Common Antibiotics Have Devastating Side Effects

by Mooslet Writing Services | May 24, 2016 | Prescription Drugs

A recent press release from the Food and Drug Administration (FDA) advises doctors to use more discretion when prescribing certain antibiotics for uncomplicated infections. The class of antibiotics known as fluoroquinolones should only be used for serious infections...

J&J Subsidiary Invests Big In Cancer Research

by Mooslet Writing Services | May 24, 2016 | Big Pharma Business

In the wake of two big legal losses for Johnson & Johnson (J&J), the company that has been accused of covering up evidence that its talc products cause cancer is now throwing the better part of a billion dollars into cancer research. How’s that for irony?...

Pfizer Pays $784 Million for Medicaid Fraud Scheme

by Mooslet Writing Services | May 19, 2016 | Big Pharma Lawsuits

Wyeth Pharmaceuticals got caught with its hand in the Medicaid cookie jar – and now parent company Pfizer must pay the consequences. New York-based Pfizer, the world’s largest pharmaceutical company, has been ordered to pay $784.6 million to federal and state...

Prescription Drug Disposal Programs Gaining Traction

by Mooslet Writing Services | May 18, 2016 | Prescription Drugs

The world’s biggest pharmaceutical companies are content to simply make drugs and sell them for handsome profits. But how do big pharma companies make sure those drugs don’t end up on the black market or in an addict’s hands? The answer: aside from one day each year,...
« Older Entries
Next Entries »

Recent Posts

  • Price-Gouging for Profit: The Rise and Fall of Valeant
  • Drug Wholesalers Settle Opioid Lawsuit
  • Lawmakers Fight To Improve Access to Generic Drugs
  • Million-Dollar Drugs: Gene Therapy No One Can Afford
  • WHO Endorses Olympics Despite Zika Virus

Recent Comments

  • Namaste927 on Lioresal
  • Mietzekatze on Maxzide
  • Jack on Zyloprim

Archives

  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • October 2015

Categories

  • Big Pharma Business
  • Big Pharma Lawsuits
  • Clinical Trials
  • Consumer Healthcare
  • FDA
  • Prescription Drugs
  • Uncategorized

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

THIS IS A PAID ATTORNEY/ADVOCATE ADVERTISEMENT. This website is a group advertisement and a fee is paid for by participating attorneys and advocates. The site is not an attorney referral service or prepaid legal services plan. The information provided by Drug Outlook is not a substitute for professional medical advice, diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of Drug Outlook. This website does not make any representation to the qualifications, expertise or credentials of participating attorneys/advocates and does not represent that quality is better than services performed by other attorneys/advocates. Any information you submit to this website may not be protected by attorney-client privilege. An automated matching system will match each request with a member attorney/advocate representing the specific geography.

If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: webmaster@drugoutlook.com

©2015 DrugOutlook.com. View our Terms of Use or Privacy Policy.